For the Inventor, By the Inventor

Enter assignee name

Ladenburg, Germany

Heidelberg Pharma Research Gmbh

USPTO Granted Patents = 16

EPO Patents = 9

Trademarks = 3

Forward Citations = 1

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Torsten Hechler (10 out of 12 patents)

Werner Simon (10 out of 17 patents)

Michael Kulke (9 out of 10 patents)

4. Christian Lutz (9 out of 12 patents)

5. Susanne Werner-Simon (8 out of 8 patents)

6. Christoph Müller (8 out of 11 patents)

7. Andreas Pahl (4 out of 9 patents)

8. Anthony Boitano (3 out of 14 patents)

9. Michael Cooke (3 out of 6 patents)

10. Jan Anderl (2 out of 6 patents)

11. Christoph Mueller (2 out of 5 patents)

12. Rahul Palchaudhuri (1 out of 9 patents)

13. Sean McDonough (1 out of 6 patents)

14. Roderich Süssmuth (1 out of 3 patents)

15. Gerhard Jas (1 out of 4 patents)

16 patents: Sort by Forward Citations

1. 12403201 - B-lymphocyte specific amatoxin antibody conjugates (2025-09-02),

2. 12403185 - Use of anti-CD137 antibody drug conjugate (ADC) in allogeneic cell therapy (2025-09-02),

3. 12378196 - Synthesis of (S)-6-hydroxytryptophan and derivatives thereof (2025-08-05),

4. 12251448 - Compositions and methods for the depletion of CD5+ cells (2025-03-18),

5. 12201693 - Amanitin conjugates (2025-01-21),

6. 12006370 - Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy (2024-06-11),

7. 11976131 - Humanized antibodies against PSMA (2024-05-07),

8. 11926631 - Method of treating cancer using amanitin derivatives (2024-03-12),

9. 11702451 - Method for synthesizing amanitins (2023-07-18),

10. 11590238 - Amanitin conjugates (2023-02-28),

11. 11584708 - Synthesis of (2S,3R,4R)-4,5-dihydroxyisoleucine and derivatives (2023-02-21),

12. 11583569 - PSMA-targeting amanitin conjugates (2023-02-21),

13. 11446388 - Amanitin antibody conjugates (2022-09-20),

14. 11420971 - Method for synthesizing amanitins (2022-08-23),

15. 10961277 - Method for synthesizing amanitins (2021-03-30),

Heidelberg Pharma Research GmbH is a biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer. The company utilizes its proprietary technology platform to create highly potent and targeted therapies that have the potential to improve patient outcomes. Heidelberg Pharma Research is committed to advancing the field of oncology through cutting-edge research and collaboration with industry partners.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#3 in Ladenburg

#2,627 in Germany

#36,634 in the World

Ladenburg, Germany

Heidelberg Pharma Research Gmbh

Forward Citations = 1

22 inventors:

Torsten Hechler (10 out of 12 patents)

Werner Simon (10 out of 17 patents)

Michael Kulke (9 out of 10 patents)

4. Christian Lutz (9 out of 12 patents)

5. Susanne Werner-Simon (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…